FY2025 · period end Dec '25 · from the 10-K filed Feb 27, 2026
Data as filed with the SEC, provided for information only — not investment advice.
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 |
|---|---|---|---|---|
| Revenue | $8.32B | $8.25B | $8.20B | $8.13B |
| Gross Profit | $4.45B | $4.59B | $4.69B | $4.70B |
| Operating Income | $2.18B | $1.04B | $1.69B | $1.69B |
| Net Income | $1.56B | $0.48B | $1.35B | $1.34B |
| EPS (Diluted) | $8.88 | $2.76 | $7.79 | $7.78 |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 |
|---|---|---|---|---|
| Total Assets | $14.29B | $14.46B | $13.94B | — |
| Total Liabilities | $9.24B | $11.50B | $2.28B | — |
| Stockholders' Equity | $5.05B | $2.96B | $11.67B | $11.74B |
| Cash & Equivalents | $0.88B | $0.76B | $0.19B | — |
| Total Debt | — | — | — | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 |
|---|---|---|---|---|
| Operating Cash Flow | $0.37B | $1.19B | $1.92B | $1.68B |
| Capital Expenditures | $0.38B | $0.38B | $0.29B | $0.25B |
| Free Cash Flow | negative: -$0.01B | $0.81B | $1.63B | $1.43B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 |
|---|---|---|---|---|
| Gross Margin | 53.5% | 55.6% | 57.3% | 57.7% |
| Operating Margin | 0.3% | 0.1% | 0.2% | 0.2% |
| Net Margin | 0.2% | 0.1% | 0.2% | 0.2% |
| Return on Equity | 38.9% | 6.6% | 11.5% | 11.4% |
| Return on Assets | 10.8% | 3.4% | 9.7% | — |
| Debt / Equity | 1.00× | 2.71× | — | — |
Showing the most recent 4 annual periods. Get 15 years of history on the Pro plan, or full history back to 1993 plus the smart-money dataset and webhooks on Institutional.
Who is buying and selling Solventum Corp — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on SOLV yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows on data pinned to its SEC filing. Be the first: run equity_research_brief on SOLV and publish the result to your public profile.
Ask about Solventum Corp
Continue in Workspace — cited answers on SOLV, a thesis you can score, or a signal on the next filing.
Open in WorkspaceGet 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate, with delisted companies kept in.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 10-Q | 0001964738-26-000047 | Jun 30, 2026 | Aug 5, 2026 | Aug 5, 2026 21:27 UTC | EDGAR |
| 10-Q | 0001964738-26-000024 | Mar 31, 2026 | May 5, 2026 | May 5, 2026 21:29 UTC | EDGAR |
| 10-K | 0001964738-26-000007 | Dec 31, 2025 | Feb 27, 2026 | Feb 27, 2026 18:40 UTC | EDGAR |
| 10-Q | 0001964738-25-000091 | Sep 30, 2025 | Nov 6, 2025 | Nov 6, 2025 22:14 UTC | EDGAR |
| 10-Q | 0001964738-25-000064 | Jun 30, 2025 | Aug 8, 2025 | Aug 7, 2025 22:13 UTC | EDGAR |
| 10-Q | 0001964738-25-000051 | Mar 31, 2025 | May 9, 2025 | May 9, 2025 16:24 UTC | EDGAR |
| 10-K | 0001964738-25-000019 | Dec 31, 2024 | Feb 28, 2025 | Feb 28, 2025 21:56 UTC | EDGAR |
| 10-Q | 0001964738-24-000044 | Sep 30, 2024 | Nov 8, 2024 | Nov 8, 2024 20:57 UTC | EDGAR |
| 10-Q | 0001964738-24-000020 | Jun 30, 2024 | Aug 9, 2024 | Aug 9, 2024 17:54 UTC | EDGAR |
| 10-Q | 0001964738-24-000013 | Mar 31, 2024 | May 10, 2024 | May 10, 2024 13:13 UTC | EDGAR |
Direct links to SEC EDGAR. SOLV has additional filings available on the SEC site.
4 numbers Solventum Corp later changed — same XBRL tag, both filings linked.
Other Accrued Liabilities, Current·As of Dec 31, 2023
Major restatementwas$262M
Revised down in a 10-K.
Deferred Tax Assets, Other·As of Dec 31, 2024
Major restatementwas$20M
Revised up in a 10-K.
Other Accrued Liabilities, Current·As of Dec 31, 2025
Major restatementwas$389M
Revised down in a 10-Q.
Selling, General and Administrative Expense·FY 2023
Notable restatementwas$2.2B
Revised up in a 10-K.
SOLV is not the only one.
See every restatement we've found across the market — or get an alert the next time SOLV revises a number.
Restatements are detected by comparing every vintage of a fact across all of Solventum Corp's filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows SOLV's most significant revisions, and a figure absent from it has not been certified as unrevised.
